Join us for this interactive symposium, where Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD; Emmanuel S. Antonarakis, MBBCh; and Heather H. Cheng, MD, PhD, provide their perspectives on PARP inhibitors in prostate cancer, including insights into their development, review of available clinical data, and how these agents may affect management strategies for patients with prostate cancer in the future.
Sign up now! Registration is complimentary.
Not an official event of the 2018 Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.
There are no upcoming events, please check back soon.